Skip to main content

Replimune Group, Inc.

REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001737953

In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Replimune Group, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of REPL: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders1351140+6
Shares48.2M27.2K53.8M+5.65M (+11.7%)
Value$1.31B$739.0K$949.0M−$360.7M (−27.5%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Replimune Group, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to REPL in Q1 2023
InstitutionSharesValue% of portfolio
Loomis Sayles & Co L P958,666$16.9M0.03%
Woodline Partners LP311,850$5.51M0.08%
Two Sigma Investments, LP254,924$4.50M0.01%
Simplify Asset Management Inc.150,000$2.65M0.47%
Qube Research & Technologies Ltd99,182$1.75M0.01%
Profund Advisors LLC40,303$711.8K0.04%
UBS Oconnor LLC39,500$697.6K0.02%
Occudo Quantitative Strategies LP38,909$687.1K0.06%
Dynamic Technology Lab Private Ltd31,800$561.0K0.05%
Gsa Capital Partners LLP23,642$418.0K0.04%
Janus Henderson Group PLC17,998$317.8K0.00%
HighVista Strategies LLC17,231$304.3K0.25%
Horizon Kinetics Asset Management LLC15,000$264.9K0.01%
E Fund Management Co., Ltd.12,305$217.0K0.02%
AQR Capital Management LLC11,164$197.2K0.00%
Fox Run Management, L.L.C.10,832$191.3K0.06%
Arizona State Retirement System10,380$183.3K0.00%
Russell Investments Group, Ltd.6,001$106.0K0.00%
Allspring Global Investments Holdings, LLC3,603$63.6K0.00%
Robeco Institutional Asset Management B.V.3,552$62.7K0.00%
Truvestments Capital LLC220$3.88K0.00%
CWM, LLC23$00.00%

Sold out (16)

Institutions that held Replimune Group, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Not filed for Q1 2023 yet (1)

Institutions that held Replimune Group, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding REPL in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Alpha Paradigm Partners, LLC27,156$739.0K